FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017129631> ?p ?o ?g. }

• W2017129631 endingPage "92" @default.
• W2017129631 startingPage "91" @default.
• W2017129631 abstract "Journal of Clinical Pharmacy and TherapeuticsVolume 33, Issue 1 p. 91-92 Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase M. Sonmez MD, M. Sonmez MD Department of Haematology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey e-mail: [email protected]Search for more papers by this authorE. Ovali MD, E. Ovali MD Department of Haematology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey e-mail: [email protected]Search for more papers by this authorS. B. Omay MD PhD, S. B. Omay MD PhD Department of Haematology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey e-mail: [email protected]Search for more papers by this author M. Sonmez MD, M. Sonmez MD Department of Haematology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey e-mail: [email protected]Search for more papers by this authorE. Ovali MD, E. Ovali MD Department of Haematology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey e-mail: [email protected]Search for more papers by this authorS. B. Omay MD PhD, S. B. Omay MD PhD Department of Haematology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey e-mail: [email protected]Search for more papers by this author First published: 17 January 2008 https://doi.org/10.1111/j.1365-2710.2008.00873.xCitations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Jabbour E, Cortes J, Kantarjian H. (2006) Novel tyrosine kinase inhibitors in chronic myelogenous leukemia. Current Opinion in Oncology, 18, 578– 583. 2 Weisberg E, Manley P, Mestan J, Cowan-Jacob S, Ray A, Griffin JD (2006) AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL. British Journal of Cancer, 94, 1765– 1769. 3 Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD (2007) Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nature Reviews. Cancer, 7, 345– 356. 4 Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. British Journal Haematology, 127, 3– 11. 5 Weisberg E, Manley PW, Breitenstein W et al. (2005) Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell, 7, 129– 141. 6 Ali R, Ozkalemkas F, Ozkan A et al. (2007) Tumour lysis syndrome with acute renal failure during imatinib therapy. Leukemia Research, 31, 573– 574. 7 Vora A, Bhutani M, Sharma A, Raina V (2002) Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase. Annals of Oncology, 13, 1833– 1834. 8 Dann EJ, Fineman R, Rowe JM (2002) Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 354– 355. Citing Literature Volume33, Issue1February 2008Pages 91-92 ReferencesRelatedInformation" @default.
• W2017129631 created "2016-06-24" @default.
• W2017129631 creator A5018463325 @default.
• W2017129631 creator A5035580081 @default.
• W2017129631 creator A5038557588 @default.
• W2017129631 date "2008-01-17" @default.
• W2017129631 modified "2023-09-27" @default.
• W2017129631 title "Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase" @default.
• W2017129631 cites W1979107490 @default.
• W2017129631 cites W2001339027 @default.
• W2017129631 cites W2069711358 @default.
• W2017129631 cites W2124196948 @default.
• W2017129631 cites W2134138207 @default.
• W2017129631 cites W2134566943 @default.
• W2017129631 cites W2138300654 @default.
• W2017129631 cites W2224095737 @default.
• W2017129631 doi "https://doi.org/10.1111/j.1365-2710.2008.00873.x" @default.
• W2017129631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18211624" @default.
• W2017129631 hasPublicationYear "2008" @default.
• W2017129631 type Work @default.
• W2017129631 sameAs 2017129631 @default.
• W2017129631 citedByCount "10" @default.
• W2017129631 countsByYear W20171296312012 @default.
• W2017129631 countsByYear W20171296312016 @default.
• W2017129631 countsByYear W20171296312017 @default.
• W2017129631 countsByYear W20171296312022 @default.
• W2017129631 crossrefType "journal-article" @default.
• W2017129631 hasAuthorship W2017129631A5018463325 @default.
• W2017129631 hasAuthorship W2017129631A5035580081 @default.
• W2017129631 hasAuthorship W2017129631A5038557588 @default.
• W2017129631 hasBestOaLocation W20171296311 @default.
• W2017129631 hasConcept C126322002 @default.
• W2017129631 hasConcept C161191863 @default.
• W2017129631 hasConcept C2986411436 @default.
• W2017129631 hasConcept C41008148 @default.
• W2017129631 hasConcept C512399662 @default.
• W2017129631 hasConcept C71924100 @default.
• W2017129631 hasConceptScore W2017129631C126322002 @default.
• W2017129631 hasConceptScore W2017129631C161191863 @default.
• W2017129631 hasConceptScore W2017129631C2986411436 @default.
• W2017129631 hasConceptScore W2017129631C41008148 @default.
• W2017129631 hasConceptScore W2017129631C512399662 @default.
• W2017129631 hasConceptScore W2017129631C71924100 @default.
• W2017129631 hasIssue "1" @default.
• W2017129631 hasLocation W20171296311 @default.
• W2017129631 hasLocation W20171296312 @default.
• W2017129631 hasOpenAccess W2017129631 @default.
• W2017129631 hasPrimaryLocation W20171296311 @default.
• W2017129631 hasRelatedWork W1574457175 @default.
• W2017129631 hasRelatedWork W1990167470 @default.
• W2017129631 hasRelatedWork W2011669067 @default.
• W2017129631 hasRelatedWork W2025794140 @default.
• W2017129631 hasRelatedWork W2553842322 @default.
• W2017129631 hasRelatedWork W4205586579 @default.
• W2017129631 hasRelatedWork W4243524731 @default.
• W2017129631 hasRelatedWork W4244510399 @default.
• W2017129631 hasRelatedWork W656393614 @default.
• W2017129631 hasRelatedWork W2611037281 @default.
• W2017129631 hasVolume "33" @default.
• W2017129631 isParatext "false" @default.
• W2017129631 isRetracted "false" @default.
• W2017129631 magId "2017129631" @default.
• W2017129631 workType "article" @default.